Patents by Inventor Sahil Khanna

Sahil Khanna has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11066711
    Abstract: Provided herein are biomarkers that can be altered in the gut of a mammal having CDI. One or more biomarkers can be used to predict Clostridium difficile infection (CDI) treatment outcome (e.g., response to primary CDI treatment and/or risk of recurrence after primary CDI treatment) in a mammal (e.g., a human) having CDI. Methods for using one or more biomarkers can be used to predict response to primary CDI treatment in a mammal having CDI. Methods for using one or more biomarkers can be used to predict risk of recurrence in a mammal having CDI. Also provided are methods of treating CDI.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: July 20, 2021
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Sahil Khanna, Purna C. Kashyap, Darrell S. Pardi
  • Publication number: 20180363033
    Abstract: Provided herein are biomarkers that can be altered in the gut of a mammal having CDI. One or more biomarkers can be used to predict Clostridium difficile infection (CDI) treatment outcome (e.g., response to primary CDI treatment and/or risk of recurrence after primary CDI treatment) in a mammal (e.g., a human) having CDI. Methods for using one or more biomarkers can be used to predict response to primary CDI treatment in a mammal having CDI. Methods for using one or more biomarkers can be used to predict risk of recurrence in a mammal having CDI. Also provided are methods of treating CDI.
    Type: Application
    Filed: December 8, 2016
    Publication date: December 20, 2018
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Sahil Khanna, Purna C. Kashyap, Darrell S. Pardi